Urology Times September 4, 2023
“The EOM may facilitate success for its oncology participants by reducing reporting burdens, simplifying requirements, and offering potentially large bonus payments for lowering costs,” writes Robert A. Dowling, MD.
Health policy makers have had their eyes on transitioning from fee-for-service reimbursement models to value-based alternatives for years. Most of the attention in this area is focused on federal spending on Medicare beneficiaries. The Centers for Medicare & Medicaid Services (CMS) includes an Innovation Center (the Center for Medicare & Medicaid Innovation, or CMMI) responsible for developing and testing new payment models, and some of these models include commercial payers and Medicaid. Several of these models have been implemented but are no longer active—including the Oncology Care Model (OCM)—and lessons learned...
Today's Sponsors
Today's Sponsor